A delayed clinical trial actually boosted Bristol Myers Squibb’s stock.
Here’s why.
-
Bristol Myers’ stock rallied Wednesday as investors maintained high hopes
for Cobenfy as an Alzheimer’s treatment, even though the outcome of a
late-stage ...
34 minutes ago







PRICES KEEP SURGING AND SOARING. This week, however, London Brent oil rocketed above �62.9 ($102) per barrel, hitting the highest level since late 2008 as traders fretted the impact of Egypt unrest on global energy supplies.
ReplyDelete